Barclays PLC Portfolio Holdings

Barclays PLC

  • $377 Billion
  • Q3 2024

Barclays PLC has filed its 13F form on November 19, 2024 for Q3 2024 where it was disclosed a total value porftolio of $377 Billion distributed in 9207 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $13.4B, Microsoft Corp with a value of $13.2B, Nvidia Corp with a value of $11.9B, Amazon Com Inc with a value of $6.33B, and Alphabet Inc. with a value of $4.93B.

Examining the 13F form we can see an decrease of $14K in the current position value, from $377B to 377B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $377 Billion
ETFs: $135 Billion
Technology: $79.1 Billion
Consumer Cyclical: $29.9 Billion
Financial Services: $28.5 Billion
Communication Services: $22.6 Billion
Healthcare: $21.3 Billion
Industrials: $17.8 Billion
Consumer Defensive: $11.7 Billion
Other: $23.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$290M
$353,000 0.0% of portfolio
39,579
Q3 2024 Added 276.05%
$52.8M
$25,000 0.0% of portfolio
9,924
Q3 2024 Reduced 2.47%
$1.02B
$1.34 Million 0.0% of portfolio
361,036
Q3 2024 Added 127.37%
$1.33B
$30,000 0.0% of portfolio
962
Q3 2024 Added 2.89%
$129M
$1.55 Million 0.0% of portfolio
105,886
Q3 2024 Added 125.91%
$3.55B
$6.21 Million 0.0% of portfolio
217,812
Q3 2024 Added 121.26%
Impact Biomedical Inc
-
$2,000 0.0% of portfolio
-
Q3 2024 New
$40.5B
$200,000 0.0% of portfolio
2,838
Q3 2024 Added 27.78%
$3.9B
$8.95 Million 0.0% of portfolio
41,321
Q3 2024 Added 39.41%
Impinj Inc
-
$1.61 Million 0.0% of portfolio
-
Q3 2024 Added 4,652.94%
$7.6M
$0 0.0% of portfolio
102
Q3 2024 New
$4.23B
$11.9 Million 0.0% of portfolio
288,079
Q3 2024 Added 9.65%
Incannex Healthcare Inc
-
$45,000 0.0% of portfolio
-
Q2 2024 Added 1,125,000.0%
$3.68M
$0 0.0% of portfolio
1,667
Q3 2023 New
$4.21B
$8.21 Million 0.0% of portfolio
400,376
Q3 2024 Added 182.3%
$2.5B
$4.58 Million 0.0% of portfolio
79,414
Q3 2024 Added 71.89%
$707M
$2.75 Million 0.0% of portfolio
82,357
Q3 2024 Added 38.12%
$0
$142,000 0.0% of portfolio
6,958
Q3 2024 Added 2.53%
$512M
$1.03 Million 0.0% of portfolio
256,799
Q3 2024 Added 330.73%
$229M
$1.17 Million 0.0% of portfolio
246,315
Q3 2024 Added 40.97%
$1.43B
$2.32 Million 0.0% of portfolio
342,859
Q3 2024 Added 383.4%
Infinera Corp
-
$1.04 Million 0.0% of portfolio
-
Q2 2024 New
Infinera Corp
-
$11,000 0.0% of portfolio
-
Q3 2024 Reduced 87.5%
$6.12B
$1.73 Million 0.0% of portfolio
68,462
Q3 2024 Reduced 25.78%
$149M
$334,000 0.0% of portfolio
101,111
Q3 2024 Added 52.52%
$164M
$192,000 0.0% of portfolio
28,597
Q3 2024 Added 300.52%
$1.44B
$2.6 Million 0.0% of portfolio
66,761
Q3 2024 Added 245.34%
$920M
$1.77 Million 0.0% of portfolio
23,689
Q3 2024 Added 346.2%
$8.75B
$6.5 Million 0.0% of portfolio
47,291
Q3 2024 Added 31.88%
Inhibrx Biosciences Inc
-
$252,000 0.0% of portfolio
-
Q3 2024 Added 348.59%
$1.33B
$2.88 Million 0.0% of portfolio
169,630
Q3 2024 Added 113.49%
$95.1M
$157,000 0.0% of portfolio
29,044
Q3 2024 Added 601.88%
$146M
$1,000 0.0% of portfolio
307
Q3 2024 Reduced 25.49%
$1B
$647,000 0.0% of portfolio
38,557
Q3 2024 Added 324.31%
$2.64B
$5.04 Million 0.0% of portfolio
44,559
Q3 2024 Added 357.11%
$512M
$154,000 0.0% of portfolio
25,614
Q3 2024 Added 288.97%
Innovate Corp
-
$0 0.0% of portfolio
-
Q3 2024 New
$1.83B
$6.46 Million 0.0% of portfolio
47,988
Q3 2024 Added 187.47%
$147M
$32,000 0.0% of portfolio
4,905
Q3 2024 New
$0
$0 0.0% of portfolio
1
Q3 2024 New
-
$12,000 0.0% of portfolio
-
Q3 2024 New
$0
$39,000 0.0% of portfolio
861
Q3 2024 New
$0
$148,000 0.0% of portfolio
4,454
Q3 2024 New
$0
$46,000 0.0% of portfolio
1,254
Q3 2024 New
$0
$279,000 0.0% of portfolio
7,164
Q3 2024 New
$0
$154,000 0.0% of portfolio
3,793
Q3 2024 New
$0
$2,000 0.0% of portfolio
59
Q3 2024 New
$0
$5,000 0.0% of portfolio
162
Q3 2024 New
$0
$202,000 0.0% of portfolio
5,859
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 9,207
  • Current Value $377 Billion
  • Prior Value $377 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 19, 2024
  • Form Type 13F-HR/A
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email